FundedIQ
Biotechnology

Integra Therapeutics: Funding, Investors & Team (Sep 2026)

Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.

integra-tx.com LinkedIn Barcelona, Spain 1-10 employees
Total raised
$17.6M
Rounds
2
Latest
Seed
Sep 2025

Integra Therapeutics has raised $17.6M across 2 funding rounds on record, the most recent a Seed of $12.5M announced in Sep 2025.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Integra Therapeutics Company Profile and Key Stats

Total funding raised
$17.6M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Seed
$12.5M in Sep 2025
Employees
1-10
reported band
Headquarters
Barcelona, Spain

Latest funding round on record: Sep 2025.

Integra Therapeutics Funding Rounds

Date
Round
Amount
Seed
$12.5M
Seed
$5.1M

Integra Therapeutics raised $5.1M in a Seed announced in Dec 2021.

3.8 years later, a Seed of $12.5M was announced in Sep 2025.

Integra Therapeutics Founders and Leadership Team

Name
Role
Contact
Avencia Sanchez-Mejias
CEO
Avencia Sánchez-Mejías
Locked

Contact details for the Integra Therapeutics team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

Integra Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
1,050
$3.1M
16,575
$3.1M

Integra Therapeutics' latest round of $12.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Integra Therapeutics in Biotechnology and Barcelona

Companies Similar to Integra Therapeutics

iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…

Seed $17.4M

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological…

Undisclosed round $8.1M

Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic…

Series B $86.6M

IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues…

Undisclosed round $2.9M

Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs…

Seed $530k

Modern medicine fails because it studies life in static environments. 60Nd revolutionizes the field with…

Undisclosed round $2.9M

Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The…

Undisclosed round $1.4M

Universal Diagnostics S.A. (UDX) is a company in Spain that specializes in in-vitro diagnostics. Their focus…

Undisclosed round $34.9M

Phyture Biotech originated as a spin-off of the Faculty of Pharmacy at the University of Barcelona, founded…

Undisclosed round $2.3M

Polimerbio offers sanitary product design and development based on biocompatible polymers, particularly…

Undisclosed round $530k

Overture Life is a biotechnology company that specializes in developing automated technologies for assisted…

Undisclosed round $23.1M

In order to cure diseases with unmet medical requirements, ARTHEx Biotech, a biotech business that was spun…

Series B $40.6M

Integra Therapeutics Funding FAQs

What does Integra Therapeutics do?

Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.

How much funding has Integra Therapeutics raised?

Integra Therapeutics has raised $17.6M across 2 rounds on record. The most recent is a Seed of $12.5M announced in Sep 2025.

When did Integra Therapeutics last raise funding?

Integra Therapeutics' most recent funding round on record is a Seed of $12.5M, announced in Sep 2025.

Who is the CEO of Integra Therapeutics?

Avencia Sanchez-Mejias is listed as CEO at Integra Therapeutics.

Where is Integra Therapeutics headquartered?

Integra Therapeutics is based in Barcelona, Catalonia, Spain.

How many employees does Integra Therapeutics have?

Integra Therapeutics is in the 1-10 employee band.

How does Integra Therapeutics' funding compare to other Biotechnology startups?

Integra Therapeutics' latest round of $12.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Integra Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Integra Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.